Cogstate LtdASX: CGS

Cogstate 1Q27 Business Update

· Issued by Cogstate Ltd via ASX

Filed with ASX · · 4 pages · English

Summary by 6ix AI

The company reported net sales contracts executed during this quarter, reflecting its strategy to enhance clinical trial endpoint data quality through partnerships. Cogstate's contracted revenue position has shown significant growth compared to the previous corresponding period, indicating a strong market presence in mood disorders.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/cogstate-1q27-business-update

Watch Cogstate's latest callCogstate (ASX:CGS) Q4 2026 Earnings Call · Replay · Aug 17Read the transcript of Cogstate (ASX:CGS) Q4 2026 Earnings Call

Release

| Page 1 ASX Announcement 12 October 2026 Cogstate 1Q27 Business Update All figures in US$, unless stated Cogstate Ltd (ASX:CGS), a global leader in clinical trial endpoint data quality and digital cognitive assessments, today releases a business update for the quarter ended 30 September 2026...

Cogstate Ltd on 6ix

Story so far

Earlier from Cogstate

Later from Cogstate

All Cogstate news releases